Molly Lamb
Concepts (389)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rural Population | 17 | 2025 | 563 | 1.660 |
Why?
| | Muscular Dystrophy, Duchenne | 6 | 2022 | 89 | 1.620 |
Why?
| | Head | 2 | 2025 | 105 | 1.570 |
Why?
| | Child Development | 5 | 2025 | 475 | 1.540 |
Why?
| | Guatemala | 27 | 2025 | 327 | 1.430 |
Why?
| | Zika Virus Infection | 6 | 2024 | 165 | 1.320 |
Why?
| | Diet | 11 | 2024 | 1278 | 1.270 |
Why?
| | Autoimmunity | 8 | 2020 | 908 | 1.160 |
Why?
| | Islets of Langerhans | 6 | 2014 | 803 | 1.030 |
Why?
| | Zika Virus | 4 | 2024 | 128 | 0.970 |
Why?
| | Dengue | 2 | 2024 | 80 | 0.940 |
Why?
| | Diabetes Mellitus, Type 1 | 12 | 2020 | 3715 | 0.870 |
Why?
| | Influenza, Human | 7 | 2025 | 622 | 0.870 |
Why?
| | Dengue Virus | 2 | 2024 | 52 | 0.810 |
Why?
| | Infant | 37 | 2025 | 9465 | 0.810 |
Why?
| | Body Weight | 2 | 2018 | 985 | 0.800 |
Why?
| | Growth Disorders | 2 | 2023 | 86 | 0.800 |
Why?
| | Body Height | 2 | 2016 | 199 | 0.750 |
Why?
| | Child, Preschool | 38 | 2025 | 11074 | 0.720 |
Why?
| | Child | 47 | 2025 | 21935 | 0.710 |
Why?
| | Infant, Newborn | 18 | 2025 | 6079 | 0.590 |
Why?
| | Microcephaly | 4 | 2024 | 98 | 0.550 |
Why?
| | Child Nutritional Physiological Phenomena | 3 | 2015 | 108 | 0.530 |
Why?
| | Humans | 88 | 2025 | 137585 | 0.520 |
Why?
| | Prospective Studies | 18 | 2025 | 7604 | 0.510 |
Why?
| | Dietary Carbohydrates | 2 | 2015 | 155 | 0.500 |
Why?
| | Pregnenediones | 1 | 2016 | 19 | 0.500 |
Why?
| | Milk | 2 | 2014 | 124 | 0.470 |
Why?
| | HLA-DR Antigens | 2 | 2014 | 228 | 0.470 |
Why?
| | Carbohydrates | 1 | 2015 | 65 | 0.460 |
Why?
| | Prednisone | 1 | 2016 | 240 | 0.460 |
Why?
| | Carbonic Anhydrases | 2 | 2005 | 14 | 0.460 |
Why?
| | Culicidae | 2 | 2005 | 37 | 0.450 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.450 |
Why?
| | Male | 47 | 2025 | 67762 | 0.400 |
Why?
| | Viruses | 3 | 2023 | 113 | 0.400 |
Why?
| | Body Mass Index | 8 | 2020 | 2389 | 0.400 |
Why?
| | Eating | 2 | 2024 | 380 | 0.400 |
Why?
| | Oryza | 2 | 2024 | 33 | 0.390 |
Why?
| | Disease Progression | 4 | 2015 | 2757 | 0.390 |
Why?
| | Infant Food | 2 | 2015 | 65 | 0.390 |
Why?
| | Female | 52 | 2025 | 73304 | 0.390 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2025 | 128 | 0.380 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2025 | 54 | 0.380 |
Why?
| | Developing Countries | 3 | 2025 | 307 | 0.380 |
Why?
| | Sarcoma, Kaposi | 2 | 2023 | 81 | 0.370 |
Why?
| | Seroepidemiologic Studies | 5 | 2023 | 165 | 0.370 |
Why?
| | Glucocorticoids | 1 | 2016 | 594 | 0.360 |
Why?
| | Immunoglobulin G | 3 | 2022 | 893 | 0.360 |
Why?
| | Global Health | 2 | 2025 | 386 | 0.360 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5472 | 0.350 |
Why?
| | Audiovisual Aids | 1 | 2010 | 12 | 0.350 |
Why?
| | Cohort Studies | 9 | 2025 | 5742 | 0.340 |
Why?
| | Sexual Maturation | 1 | 2010 | 55 | 0.340 |
Why?
| | Hyperlipidemias | 1 | 2011 | 120 | 0.340 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 106 | 0.330 |
Why?
| | Pregnancy | 12 | 2024 | 6763 | 0.330 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1329 | 0.320 |
Why?
| | Antibodies, Viral | 6 | 2023 | 625 | 0.320 |
Why?
| | Virus Diseases | 2 | 2022 | 212 | 0.320 |
Why?
| | Overweight | 3 | 2019 | 558 | 0.310 |
Why?
| | Risk Factors | 13 | 2025 | 10388 | 0.300 |
Why?
| | Self Concept | 1 | 2010 | 253 | 0.300 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2005 | 14 | 0.300 |
Why?
| | Adolescent | 21 | 2025 | 21513 | 0.300 |
Why?
| | Meningitis, Bacterial | 2 | 2022 | 47 | 0.300 |
Why?
| | Glycemic Index | 1 | 2008 | 27 | 0.290 |
Why?
| | Delivery, Obstetric | 2 | 2019 | 144 | 0.290 |
Why?
| | Caregivers | 3 | 2021 | 877 | 0.290 |
Why?
| | Autoantibodies | 5 | 2020 | 1496 | 0.290 |
Why?
| | Obesity | 5 | 2015 | 2992 | 0.280 |
Why?
| | Caliciviridae Infections | 2 | 2018 | 20 | 0.280 |
Why?
| | Norovirus | 2 | 2018 | 26 | 0.280 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 5778 | 0.270 |
Why?
| | Interviews as Topic | 1 | 2010 | 786 | 0.270 |
Why?
| | Respiratory Tract Infections | 2 | 2022 | 390 | 0.270 |
Why?
| | Lipids | 2 | 2011 | 672 | 0.270 |
Why?
| | Body Composition | 1 | 2011 | 684 | 0.270 |
Why?
| | Viral Vaccines | 2 | 2018 | 98 | 0.270 |
Why?
| | Vaccination | 3 | 2025 | 1381 | 0.270 |
Why?
| | Psychology, Child | 1 | 2007 | 38 | 0.270 |
Why?
| | Adipose Tissue | 1 | 2011 | 635 | 0.260 |
Why?
| | Gastroenteritis | 2 | 2017 | 69 | 0.260 |
Why?
| | Genotype | 4 | 2015 | 1916 | 0.260 |
Why?
| | Mental Health Services | 2 | 2021 | 421 | 0.250 |
Why?
| | Herpesvirus 8, Human | 2 | 2023 | 65 | 0.250 |
Why?
| | Adult | 21 | 2025 | 37929 | 0.250 |
Why?
| | Young Adult | 16 | 2025 | 13209 | 0.240 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2025 | 74 | 0.240 |
Why?
| | Blood Culture | 1 | 2025 | 23 | 0.230 |
Why?
| | Gastrointestinal Tract | 2 | 2019 | 195 | 0.230 |
Why?
| | Ectoparasitic Infestations | 1 | 2024 | 5 | 0.230 |
Why?
| | Masks | 2 | 2022 | 63 | 0.230 |
Why?
| | Animals, Domestic | 1 | 2024 | 17 | 0.230 |
Why?
| | Nasopharynx | 1 | 2025 | 76 | 0.230 |
Why?
| | Schools | 4 | 2023 | 461 | 0.230 |
Why?
| | Digestive System | 1 | 2004 | 27 | 0.220 |
Why?
| | Niacin | 1 | 2024 | 17 | 0.220 |
Why?
| | Income | 1 | 2025 | 202 | 0.210 |
Why?
| | Culex | 1 | 2023 | 16 | 0.210 |
Why?
| | Coinfection | 2 | 2022 | 137 | 0.210 |
Why?
| | Educational Personnel | 1 | 2023 | 11 | 0.210 |
Why?
| | Saliva | 1 | 2025 | 242 | 0.210 |
Why?
| | Antimicrobial Stewardship | 1 | 2025 | 118 | 0.200 |
Why?
| | Aedes | 1 | 2023 | 65 | 0.200 |
Why?
| | HIV Seropositivity | 1 | 2023 | 125 | 0.200 |
Why?
| | Bacteremia | 1 | 2025 | 214 | 0.200 |
Why?
| | Cross Reactions | 1 | 2022 | 133 | 0.190 |
Why?
| | Metapneumovirus | 1 | 2022 | 16 | 0.190 |
Why?
| | Diarrhea | 2 | 2023 | 184 | 0.190 |
Why?
| | Cephalometry | 1 | 2022 | 33 | 0.190 |
Why?
| | Neurodevelopmental Disorders | 1 | 2024 | 181 | 0.190 |
Why?
| | Prevalence | 8 | 2021 | 2734 | 0.190 |
Why?
| | Anthropometry | 1 | 2022 | 213 | 0.180 |
Why?
| | Parents | 3 | 2023 | 1347 | 0.180 |
Why?
| | Erythrocyte Membrane | 2 | 2015 | 55 | 0.180 |
Why?
| | Cesarean Section | 2 | 2019 | 184 | 0.180 |
Why?
| | Sexually Transmitted Diseases, Viral | 1 | 2021 | 10 | 0.180 |
Why?
| | Family Health | 2 | 2015 | 196 | 0.180 |
Why?
| | Health Literacy | 1 | 2023 | 168 | 0.180 |
Why?
| | Lead Poisoning | 1 | 2021 | 19 | 0.180 |
Why?
| | Midwifery | 1 | 2022 | 52 | 0.170 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1266 | 0.170 |
Why?
| | Pandemics | 3 | 2025 | 1639 | 0.170 |
Why?
| | Meningitis | 1 | 2022 | 79 | 0.170 |
Why?
| | Arsenic | 1 | 2021 | 64 | 0.170 |
Why?
| | Malaria | 1 | 2021 | 63 | 0.170 |
Why?
| | Emergency Responders | 1 | 2021 | 36 | 0.170 |
Why?
| | Socioeconomic Factors | 1 | 2025 | 1289 | 0.170 |
Why?
| | Birth Intervals | 1 | 2020 | 23 | 0.170 |
Why?
| | Motivation | 1 | 2025 | 570 | 0.170 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2015 | 140 | 0.170 |
Why?
| | Lysine | 1 | 2022 | 294 | 0.170 |
Why?
| | Specimen Handling | 1 | 2022 | 183 | 0.170 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 105 | 0.170 |
Why?
| | Maternal Health Services | 1 | 2022 | 98 | 0.170 |
Why?
| | Endpoint Determination | 1 | 2020 | 77 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 852 | 0.160 |
Why?
| | Cesarean Section, Repeat | 1 | 2019 | 11 | 0.160 |
Why?
| | Age of Onset | 4 | 2022 | 518 | 0.160 |
Why?
| | Vaginal Birth after Cesarean | 1 | 2019 | 25 | 0.160 |
Why?
| | Regression Analysis | 1 | 2022 | 1024 | 0.160 |
Why?
| | Refugees | 1 | 2021 | 75 | 0.160 |
Why?
| | Language Tests | 1 | 2019 | 23 | 0.160 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5131 | 0.160 |
Why?
| | Breast Feeding | 4 | 2015 | 440 | 0.160 |
Why?
| | Sexual Partners | 1 | 2021 | 186 | 0.160 |
Why?
| | Language Development Disorders | 1 | 2019 | 41 | 0.150 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2021 | 233 | 0.150 |
Why?
| | Dietary Proteins | 2 | 2013 | 135 | 0.150 |
Why?
| | Motor Skills | 1 | 2020 | 97 | 0.150 |
Why?
| | Adolescent Health | 1 | 2019 | 39 | 0.150 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 36 | 0.150 |
Why?
| | Sensitivity and Specificity | 5 | 2025 | 1946 | 0.150 |
Why?
| | Arbovirus Infections | 1 | 2018 | 21 | 0.150 |
Why?
| | Epilepsy | 1 | 2022 | 333 | 0.150 |
Why?
| | Social Class | 2 | 2010 | 282 | 0.150 |
Why?
| | Public Health Surveillance | 1 | 2018 | 82 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 394 | 0.140 |
Why?
| | Sexual Behavior | 2 | 2021 | 485 | 0.140 |
Why?
| | Emergency Service, Hospital | 4 | 2022 | 2069 | 0.140 |
Why?
| | HLA-DQ beta-Chains | 2 | 2015 | 63 | 0.140 |
Why?
| | HLA-DR4 Antigen | 2 | 2015 | 78 | 0.140 |
Why?
| | HLA-DR3 Antigen | 2 | 2015 | 80 | 0.140 |
Why?
| | Linear Models | 3 | 2023 | 849 | 0.140 |
Why?
| | Vaccines | 1 | 2023 | 406 | 0.140 |
Why?
| | Sentinel Surveillance | 1 | 2017 | 49 | 0.140 |
Why?
| | Medicaid | 1 | 2021 | 435 | 0.140 |
Why?
| | Celiac Disease | 1 | 2020 | 294 | 0.130 |
Why?
| | Sex Factors | 4 | 2010 | 2071 | 0.130 |
Why?
| | Cell Phone | 1 | 2017 | 76 | 0.130 |
Why?
| | Family Characteristics | 4 | 2021 | 191 | 0.130 |
Why?
| | Urban Population | 1 | 2019 | 479 | 0.130 |
Why?
| | Micronutrients | 2 | 2007 | 92 | 0.130 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3284 | 0.130 |
Why?
| | Neonatal Screening | 1 | 2017 | 169 | 0.120 |
Why?
| | Fever | 1 | 2017 | 306 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 539 | 0.120 |
Why?
| | Health Resources | 1 | 2017 | 120 | 0.120 |
Why?
| | Learning | 1 | 2020 | 409 | 0.120 |
Why?
| | Feeding Methods | 1 | 2015 | 6 | 0.120 |
Why?
| | F2-Isoprostanes | 1 | 2015 | 21 | 0.120 |
Why?
| | Models, Psychological | 1 | 2017 | 301 | 0.120 |
Why?
| | Methazolamide | 2 | 2005 | 4 | 0.120 |
Why?
| | Oxygen Isotopes | 2 | 2005 | 25 | 0.120 |
Why?
| | Acetazolamide | 2 | 2005 | 26 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1809 | 0.120 |
Why?
| | Down Syndrome | 1 | 2021 | 496 | 0.110 |
Why?
| | Histocytochemistry | 2 | 2005 | 80 | 0.110 |
Why?
| | Mobile Applications | 1 | 2017 | 183 | 0.110 |
Why?
| | Energy Intake | 2 | 2008 | 485 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2015 | 61 | 0.110 |
Why?
| | District of Columbia | 2 | 2012 | 28 | 0.110 |
Why?
| | Food Supply | 1 | 2015 | 83 | 0.110 |
Why?
| | Chickens | 2 | 2024 | 191 | 0.110 |
Why?
| | Population Surveillance | 1 | 2017 | 482 | 0.110 |
Why?
| | Age Factors | 5 | 2015 | 3295 | 0.110 |
Why?
| | Walking | 1 | 2018 | 529 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 530 | 0.100 |
Why?
| | United States | 9 | 2021 | 14841 | 0.100 |
Why?
| | Animals | 8 | 2024 | 36940 | 0.100 |
Why?
| | Species Specificity | 2 | 2005 | 585 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2005 | 560 | 0.100 |
Why?
| | Health Behavior | 1 | 2019 | 762 | 0.100 |
Why?
| | Social Support | 1 | 2017 | 618 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2021 | 3556 | 0.100 |
Why?
| | Seroconversion | 2 | 2023 | 46 | 0.100 |
Why?
| | Kenya | 2 | 2023 | 118 | 0.100 |
Why?
| | Contact Tracing | 1 | 2012 | 27 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 806 | 0.090 |
Why?
| | Psychometrics | 3 | 2021 | 720 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 347 | 0.090 |
Why?
| | Transportation | 1 | 2012 | 53 | 0.090 |
Why?
| | Personal Protective Equipment | 2 | 2022 | 52 | 0.090 |
Why?
| | Insulin | 2 | 2015 | 2409 | 0.090 |
Why?
| | Quality Improvement | 4 | 2022 | 1178 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2057 | 0.090 |
Why?
| | School Teachers | 2 | 2021 | 23 | 0.090 |
Why?
| | Mass Spectrometry | 2 | 2005 | 739 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 984 | 0.090 |
Why?
| | Area Under Curve | 2 | 2009 | 314 | 0.090 |
Why?
| | Acute Disease | 3 | 2019 | 1007 | 0.090 |
Why?
| | HLA Antigens | 2 | 2013 | 240 | 0.090 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2012 | 141 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 581 | 0.090 |
Why?
| | Nutrition Surveys | 4 | 2015 | 266 | 0.080 |
Why?
| | ROC Curve | 2 | 2009 | 554 | 0.080 |
Why?
| | Fetal Weight | 1 | 2009 | 56 | 0.080 |
Why?
| | Quality of Life | 2 | 2022 | 2892 | 0.080 |
Why?
| | Chikungunya Fever | 2 | 2021 | 79 | 0.080 |
Why?
| | HIV Infections | 1 | 2023 | 2836 | 0.080 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 314 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2022 | 15657 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2017 | 1100 | 0.070 |
Why?
| | Solanum tuberosum | 1 | 2008 | 7 | 0.070 |
Why?
| | Middle Aged | 8 | 2025 | 33479 | 0.070 |
Why?
| | Edible Grain | 1 | 2008 | 49 | 0.070 |
Why?
| | Pregnancy in Diabetics | 1 | 2009 | 123 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2009 | 170 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 654 | 0.070 |
Why?
| | Bias | 1 | 2009 | 218 | 0.070 |
Why?
| | Radiographic Image Enhancement | 1 | 2007 | 58 | 0.070 |
Why?
| | Self Disclosure | 1 | 2007 | 63 | 0.070 |
Why?
| | Vegetables | 1 | 2008 | 157 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2010 | 956 | 0.060 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2844 | 0.060 |
Why?
| | Vitamins | 2 | 2024 | 185 | 0.060 |
Why?
| | Birth Weight | 1 | 2009 | 516 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 910 | 0.060 |
Why?
| | Mental Health | 2 | 2023 | 726 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2007 | 431 | 0.060 |
Why?
| | Weight Gain | 1 | 2009 | 519 | 0.060 |
Why?
| | Mammography | 1 | 2007 | 154 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1509 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2189 | 0.060 |
Why?
| | Students | 2 | 2023 | 622 | 0.060 |
Why?
| | Risk | 2 | 2021 | 912 | 0.060 |
Why?
| | Influenza B virus | 1 | 2025 | 44 | 0.060 |
Why?
| | Mental Recall | 1 | 2007 | 202 | 0.060 |
Why?
| | Anaplasma | 1 | 2024 | 2 | 0.060 |
Why?
| | Ehrlichia | 1 | 2024 | 3 | 0.060 |
Why?
| | Rickettsia | 1 | 2024 | 9 | 0.060 |
Why?
| | Bartonella | 1 | 2024 | 7 | 0.060 |
Why?
| | Siphonaptera | 1 | 2024 | 15 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2013 | 2426 | 0.060 |
Why?
| | Dietary Fats | 1 | 2007 | 304 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1023 | 0.060 |
Why?
| | Ticks | 1 | 2024 | 25 | 0.060 |
Why?
| | Cats | 1 | 2024 | 210 | 0.060 |
Why?
| | Influenza A virus | 1 | 2025 | 107 | 0.050 |
Why?
| | Prognosis | 1 | 2013 | 4030 | 0.050 |
Why?
| | Nutritional Status | 1 | 2007 | 350 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 2007 | 261 | 0.050 |
Why?
| | Dog Diseases | 1 | 2024 | 64 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 691 | 0.050 |
Why?
| | Mosquito Vectors | 1 | 2023 | 30 | 0.050 |
Why?
| | Dogs | 1 | 2024 | 413 | 0.050 |
Why?
| | Magnesium | 1 | 2024 | 156 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2023 | 7635 | 0.050 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2009 | 605 | 0.050 |
Why?
| | Databases, Factual | 2 | 2019 | 1357 | 0.050 |
Why?
| | Larva | 1 | 2004 | 226 | 0.050 |
Why?
| | Pyridoxine | 1 | 2022 | 36 | 0.050 |
Why?
| | Vomiting | 1 | 2023 | 130 | 0.050 |
Why?
| | Vital Signs | 1 | 2022 | 43 | 0.050 |
Why?
| | Cough | 1 | 2023 | 122 | 0.050 |
Why?
| | Swine | 1 | 2024 | 775 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 117 | 0.050 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2022 | 100 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 283 | 0.050 |
Why?
| | Fermentation | 1 | 2021 | 26 | 0.050 |
Why?
| | Food Contamination | 1 | 2021 | 49 | 0.050 |
Why?
| | Hospitalization | 2 | 2022 | 2199 | 0.050 |
Why?
| | Methylene Blue | 1 | 2021 | 24 | 0.040 |
Why?
| | World Health Organization | 1 | 2022 | 123 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 329 | 0.040 |
Why?
| | Equipment Reuse | 1 | 2021 | 16 | 0.040 |
Why?
| | Phenotype | 2 | 2022 | 3196 | 0.040 |
Why?
| | Decontamination | 1 | 2021 | 30 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 259 | 0.040 |
Why?
| | Hot Temperature | 1 | 2024 | 391 | 0.040 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2021 | 45 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 173 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 109 | 0.040 |
Why?
| | Brazil | 1 | 2021 | 167 | 0.040 |
Why?
| | Immunization | 1 | 2023 | 411 | 0.040 |
Why?
| | Lead | 1 | 2021 | 64 | 0.040 |
Why?
| | Colorado | 2 | 2021 | 4565 | 0.040 |
Why?
| | India | 1 | 2021 | 195 | 0.040 |
Why?
| | Diet Surveys | 2 | 2013 | 95 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 289 | 0.040 |
Why?
| | Mass Screening | 1 | 2009 | 1287 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 499 | 0.040 |
Why?
| | Translations | 1 | 2020 | 17 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 49 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 165 | 0.040 |
Why?
| | Chikungunya virus | 1 | 2021 | 80 | 0.040 |
Why?
| | Child Language | 1 | 2019 | 19 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2021 | 184 | 0.040 |
Why?
| | Parity | 1 | 2019 | 126 | 0.040 |
Why?
| | Triage | 1 | 2021 | 222 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 294 | 0.040 |
Why?
| | Translating | 1 | 2019 | 43 | 0.040 |
Why?
| | Rural Health | 1 | 2019 | 80 | 0.040 |
Why?
| | Dengue Vaccines | 1 | 2018 | 10 | 0.040 |
Why?
| | Parasites | 1 | 2019 | 50 | 0.040 |
Why?
| | Arboviruses | 1 | 2018 | 16 | 0.040 |
Why?
| | Culturally Competent Care | 1 | 2019 | 63 | 0.040 |
Why?
| | RNA, Viral | 1 | 2022 | 656 | 0.040 |
Why?
| | Thinness | 1 | 2019 | 91 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1710 | 0.040 |
Why?
| | Seasons | 1 | 2021 | 547 | 0.040 |
Why?
| | Blood Glucose | 1 | 2008 | 2186 | 0.040 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 83 | 0.040 |
Why?
| | Rare Diseases | 1 | 2018 | 104 | 0.040 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 530 | 0.040 |
Why?
| | Proteins | 1 | 2004 | 1009 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2019 | 163 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 416 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 255 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 170 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2021 | 546 | 0.030 |
Why?
| | Mothers | 1 | 2023 | 754 | 0.030 |
Why?
| | Child Health | 1 | 2019 | 154 | 0.030 |
Why?
| | Medical Records | 1 | 2018 | 177 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 488 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 514 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 71 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1020 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2031 | 0.030 |
Why?
| | Child Behavior | 1 | 2019 | 248 | 0.030 |
Why?
| | Aged | 3 | 2025 | 23961 | 0.030 |
Why?
| | Research Design | 1 | 2023 | 1139 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2074 | 0.030 |
Why?
| | Telemedicine | 1 | 2025 | 862 | 0.030 |
Why?
| | Risk-Taking | 1 | 2019 | 348 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 601 | 0.030 |
Why?
| | Life Change Events | 1 | 2017 | 151 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 93 | 0.030 |
Why?
| | Data Collection | 1 | 2018 | 673 | 0.030 |
Why?
| | Cities | 1 | 2015 | 133 | 0.030 |
Why?
| | Cognition | 1 | 2022 | 1153 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2253 | 0.030 |
Why?
| | Public Health | 1 | 2018 | 588 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6828 | 0.020 |
Why?
| | Bacteria | 1 | 2019 | 858 | 0.020 |
Why?
| | Health Promotion | 1 | 2019 | 741 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 344 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2828 | 0.020 |
Why?
| | Automobiles | 1 | 2012 | 19 | 0.020 |
Why?
| | Virginia | 1 | 2012 | 62 | 0.020 |
Why?
| | Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 60 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1325 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1622 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 377 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3457 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 655 | 0.020 |
Why?
| | Biomarkers | 2 | 2015 | 4149 | 0.020 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 97 | 0.020 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2007 | 48 | 0.020 |
Why?
| | Environmental Exposure | 1 | 2012 | 579 | 0.020 |
Why?
| | Carotenoids | 1 | 2007 | 43 | 0.020 |
Why?
| | Research Personnel | 1 | 2009 | 173 | 0.020 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2007 | 146 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2009 | 421 | 0.010 |
Why?
| | Models, Statistical | 1 | 2009 | 669 | 0.010 |
Why?
| | Early Detection of Cancer | 1 | 2009 | 447 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2007 | 1050 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|